mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |